Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
12.04
-0.49 (-3.91%)
Jul 13, 2026, 10:01 AM EDT - Market open
TNXP Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -147.39 | -124.02 | -130.04 | -116.66 | -110.22 | -92.29 |
Depreciation & Amortization | 1.99 | 1.93 | 3.42 | 4.29 | 1.25 | 0.05 |
Stock-Based Compensation | 7.11 | 6.02 | 4.78 | 9.28 | 10.91 | 7.9 |
Other Adjustments | 0.45 | 5.85 | 55.14 | 1.12 | - | 3 |
Change in Receivables | -5.54 | -2.62 | -3.68 | - | - | - |
Changes in Inventories | 3.82 | 1.73 | 3.74 | 0.06 | - | - |
Changes in Accounts Payable | 4.88 | 2.99 | 0.93 | -3.49 | -1.05 | 3.53 |
Changes in Accrued Expenses | 12.63 | 11.75 | 1.19 | 1.79 | 1.21 | 1.75 |
Changes in Other Operating Activities | -6.78 | -3.46 | 3.6 | 1.61 | -0.16 | 0.51 |
Operating Cash Flow | -125.58 | -99.84 | -60.93 | -102 | -98.05 | -75.56 |
Capital Expenditures | -5.06 | -3.37 | -0.12 | -7.9 | -48.15 | -35.31 |
Sale of Property, Plant & Equipment | - | - | - | 1 | - | - |
Payments for Business Acquisitions | - | - | - | -22.17 | - | - |
Other Investing Activities | -1.01 | -1.16 | - | - | - | - |
Investing Cash Flow | -6.21 | -4.53 | -0.12 | -29.07 | -48.15 | -35.31 |
Long-Term Debt Issued | - | - | - | 8.94 | - | - |
Long-Term Debt Repaid | - | -9.65 | -2.35 | - | - | - |
Net Long-Term Debt Issued (Repaid) | - | -9.65 | -2.35 | 8.94 | - | - |
Issuance of Common Stock | 220.08 | 237.94 | 140.22 | 41.54 | 94.5 | 212.49 |
Repurchase of Common Stock | -10.71 | -13.76 | - | -13.97 | - | - |
Net Common Stock Issued (Repurchased) | 209.37 | 224.18 | 140.22 | 27.58 | 94.5 | 212.49 |
Issuance of Preferred Stock | - | - | - | - | 40.59 | - |
Repurchase of Preferred Stock | - | - | - | - | -47.25 | - |
Net Preferred Stock Issued (Repurchased) | - | - | - | - | -6.66 | - |
Other Financing Activities | - | - | -3 | - | - | - |
Financing Cash Flow | 185.2 | 214.53 | 134.87 | 36.52 | 87.84 | 212.49 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -0.02 | -0.03 | 0 | -0.07 | -0.07 | -0.03 |
Net Cash Flow | 53.39 | 110.13 | 73.83 | -94.62 | -58.43 | 101.59 |
Free Cash Flow | -130.64 | -103.21 | -61.05 | -109.9 | -146.2 | -110.86 |
FCF Margin | -744.12% | -787.47% | -604.76% | -1414.75% | - | - |
Free Cash Flow Per Share | -12.51 | -12.13 | -82.90 | -13867.30 | -80089.70 | -194715.00 |
Levered Free Cash Flow | -135.9 | -122.11 | -119.63 | -111.36 | -163.77 | -121.76 |
Unlevered Free Cash Flow | -139.7 | -114.15 | -123.94 | -122.02 | -158.99 | -121.79 |